Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
Authors
Keywords
siRNA, Breast cancer, Lipopolyplex, Aptamer, siRNA delivery, Notch 1
Journal
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 65, Issue -, Pages 102733
Publisher
Elsevier BV
Online
2021-07-17
DOI
10.1016/j.jddst.2021.102733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted drug delivery strategies for precision medicines
- (2021) Mandana T. Manzari et al. Nature Reviews Materials
- siRNA: Mechanism of action, challenges, and therapeutic approaches
- (2021) Walhan Alshaer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
- (2021) Chiara Brignole et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Carcinogenesis of Triple-Negative Breast Cancer and Sex Steroid Hormones
- (2021) Naoko Honma et al. Cancers
- Recent advancements in liposome technology
- (2020) Nina Filipczak et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
- (2020) Chi Zhang et al. LIFE SCIENCES
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drugging an undruggable pocket on KRAS
- (2019) Dirk Kessler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
- (2019) M. V. Giuli et al. Journal of Oncology
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
- (2018) M. Danaei et al. Pharmaceutics
- Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
- (2017) Jenny G Parvani et al. ENDOCRINE-RELATED CANCER
- The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin
- (2016) Hang Xing et al. CHEMBIOCHEM
- Low molecular weight chitosan–protamine conjugate for siRNA delivery with enhanced stability and transfection efficiency
- (2016) Sushilkumar Patil et al. RSC Advances
- Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination
- (2015) Nuno A. Fonseca et al. BIOMATERIALS
- Liposomes as siRNA Delivery Vectors
- (2015) Sabrina Bochicchio et al. CURRENT DRUG METABOLISM
- Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
- (2015) Elisabetta Benedetti et al. Oncotarget
- Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging
- (2015) Kerong Deng et al. Scientific Reports
- Triple-Negative Breast Carcinoma
- (2014) Robert Schmadeka et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity
- (2014) Peter Vrtačnik et al. ANALYTICAL BIOCHEMISTRY
- Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
- (2014) Walhan Alshaer et al. BIOCONJUGATE CHEMISTRY
- Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4
- (2014) XING AI et al. ONCOLOGY REPORTS
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
- (2013) Hang Xing et al. Journal of Materials Chemistry B
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides
- (2010) Leaf Huang et al. JOURNAL OF DRUG TARGETING
- Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes
- (2009) Zehui Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design of peptide-targeted liposomes containing nucleic acids
- (2009) Adriana O. Santos et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Chemically modified siRNA: tools and applications
- (2008) J WATTS et al. DRUG DISCOVERY TODAY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started